CRDF R&D to Revenue
Cardiff Oncology Inc · R&D to Revenue
CRDF R&D to Revenue
Latest reported5687.50%period ending
CRDF Quarterly R&D/Revenue (0.00% → 5687.50%)
Latest values, visible window
High-resolution chart · PNG
CRDF r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5,687.5% | |
| 16,500% | |
| 2,088.4774% | |
| 6,830.8333% | |
| 9,570.2479% | |
| 9,611.9266% | |
| 6,431.7881% | |
| 5,842.4242% | |
| 5,823.9264% | |
| 3,906.3415% | |
| 4,976.2821% | |
| 5,689.3617% | |
| 7,425.9259% | |
| 10,906.0241% | |
| 5,032.8125% | |
| 6,461.2903% | |
| 8,184.6154% | |
| 9,740.5405% | |
| 4,378.9474% | |
| 4,830.2326% | |
| 6,057.3529% | |
| 4,554.1667% | |
| 2,682.6305% | |
| 2,099.2647% | |
| 5,758.1395% | |
| 3,979.4118% | |
| 3,094.1519% | |
| 5,453.6421% | |
| 2,050.7246% | |
| 1,635.1852% | |
| 3,201.2821% | |
| 2,071.5485% | |
| 1,746.4579% | |
| 1,881.2795% | |
| 652.4324% | |
| 1,147.0992% | |
| 962.3619% | |
| 4,503.2829% | |
| 5,566.1765% | |
| 4,418.3832% | |
| 3,942.3733% | |
| 2,662.6031% | |
| 4,007.5949% | |
| 4,442.118% | |
| 5,368% | |
| 1,730.849% | |
| 3,276.7857% | |
| 3,479.5206% | |
| 2,511.6362% | |
| 1,300.119% | |
| 2,715.0506% | |
| 2,092.1862% | |
| 1,926.2224% | |
| 673.4594% | |
| 364.4172% | |
| 241.8123% | |
| 1,149.7614% | |
| 987.9279% | |
| 913.9467% | |
| 365.3164% | |
| 179.4173% | |
| 289.6388% | |
| -200% | |
| 0% | |
| 1,150% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |